HALP Score and Cancer Survival
Author Information
Author(s): Li Jinze, Zheng Jing, Wang Puze, Lv Dong
Primary Institution: People’s Hospital of Deyang City, Chengdu University of Traditional Chinese Medicine, Deyang, China
Hypothesis
The HALP score can serve as a prognostic indicator for survival outcomes in patients with solid tumors.
Conclusion
High HALP scores are associated with better survival outcomes in patients with solid tumors.
Supporting Evidence
- Elevated HALP score was significantly associated with favorable overall survival.
- HALP score is a potential prognostic biomarker in solid tumors.
- Subgroup analyses revealed consistent prognostic impact of HALP across different cancer types.
Takeaway
If you have higher levels of hemoglobin, albumin, lymphocytes, and platelets, you might live longer if you have cancer.
Methodology
A meta-analysis was conducted following PRISMA guidelines, pooling data from studies that reported risk ratios and confidence intervals.
Potential Biases
Potential bias due to the retrospective nature of most studies and variability in HALP cut-off values.
Limitations
The majority of included studies were retrospective, which increases the risk of bias.
Participant Demographics
Included 17,049 patients with various solid tumors from multiple countries.
Statistical Information
P-Value
<0.01
Confidence Interval
95% CI 0.54-0.67
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website